These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
566 related articles for article (PubMed ID: 3884171)
1. Mutagenic activation of carcinogenic N-nitrosopropylamines by rat liver: evidence for a cytochrome P-450 dependent reaction. Mori Y; Yamazaki H; Toyoshi K; Makino T; Obara T; Yokose Y; Konishi Y Carcinogenesis; 1985 Mar; 6(3):415-20. PubMed ID: 3884171 [TBL] [Abstract][Full Text] [Related]
2. A comparative study of the mutagenic activation of N-nitrosopropylamines by various animal species and man: evidence for a cytochrome P-450 dependent reaction. Yamazaki H; Mori Y; Toyoshi K; Nagai H; Koda A; Konishi Y Jpn J Cancer Res; 1986 Feb; 77(2):107-17. PubMed ID: 3082822 [TBL] [Abstract][Full Text] [Related]
3. Activation of carcinogenic N-nitrosopropylamines to mutagens by lung and pancreas S9 fractions from various animal species and man. Mori Y; Yamazaki H; Toyoshi K; Maruyama H; Konishi Y Mutat Res; 1986 May; 160(3):159-69. PubMed ID: 3960034 [TBL] [Abstract][Full Text] [Related]
4. Mutagenic activation of carcinogenic N-nitrosopropylamines by liver S9 fractions from mice, rats and hamsters: evidence for a cytochrome P-450-dependent reaction. Mori Y; Yamazaki H; Toyoshi K; Denda A; Konishi Y Carcinogenesis; 1986 Mar; 7(3):375-9. PubMed ID: 3512116 [TBL] [Abstract][Full Text] [Related]
5. Participation of phenobarbital-inducible cytochrome P450 in the mutagenic activation of N-nitrosopropylamines by liver and lung 9000 g fractions from five animal species and man. Mori Y; Konishi Y IARC Sci Publ; 1991; (105):398-403. PubMed ID: 1855888 [TBL] [Abstract][Full Text] [Related]
6. Mutagenicity of N-nitrosobis(2-hydroxypropyl)amine and its related compounds in the presence of rat lung and liver S9. Mori Y; Niwa T; Takahashi H; Toyoshi K; Denda A; Takahashi S; Konishi Y Cancer Lett; 1983 Apr; 18(3):271-5. PubMed ID: 6406040 [TBL] [Abstract][Full Text] [Related]
7. A comparative study of the mutagenic activation of carcinogenic N-nitrosopropylamines by various animal species and man. Mori Y; Yamazaki H; Konishi Y IARC Sci Publ; 1987; (84):141-3. PubMed ID: 3679352 [TBL] [Abstract][Full Text] [Related]
8. Species specificity in the metabolism of N-nitrosobis(2-oxopropyl)amine and N-nitroso(2-hydroxypropyl)(2-oxopropyl)amine to mutagens by isolated rat and hamster hepatocytes. Mangino MM; Hollenberg PF; Scarpelli DG Cancer Res; 1987 Sep; 47(18):4776-81. PubMed ID: 3113724 [TBL] [Abstract][Full Text] [Related]
9. Effect of cigarette smoke on the mutagenic activation of various carcinogens in hamster. Mori Y; Iimura K; Furukawa F; Nishikawa A; Takahashi M; Konishi Y Mutat Res; 1995 Jan; 346(1):1-8. PubMed ID: 7530323 [TBL] [Abstract][Full Text] [Related]
10. Mutagenicity of several pancreatic carcinogenic derivatives of N-nitrosodipropylamine in the Ames assay. Wislocki P; Gingell R Mutat Res; 1980 Mar; 77(3):215-9. PubMed ID: 6991919 [TBL] [Abstract][Full Text] [Related]
11. Activation of N-nitrosobis(2-oxopropyl)amine and N-nitroso(2-hydroxypropyl)-(2-oxopropyl)amine to mutagens for V79 cells by isolated hamster and rat pancreatic acinar cells. Mangino MM; Scarpelli DG; Hollenberg PF Cancer Res; 1985 Nov; 45(11 Pt 1):5219-24. PubMed ID: 4053002 [TBL] [Abstract][Full Text] [Related]
12. Participation of cytochrome P450 in mutagenic activation of the carcinogen 3'-hydroxymethyl-N,N-dimethyl-4-aminoazobenzene and its N-demethylated compounds by rat liver. Mori Y; Niwa T; Toyoshi K Mutat Res; 1983 Oct; 122(1):13-22. PubMed ID: 6413856 [TBL] [Abstract][Full Text] [Related]
13. Metabolism of pancreatic carcinogens N-nitroso-2,6-dimethylmorpholine and N-nitrosobis(2-oxopropyl)amine by microsomes and cytosol of hamster pancreas and liver. Kokkinakis DM; Scarpelli DG; Rao MS; Hollenberg PF Cancer Res; 1983 Dec; 43(12 Pt 1):5761-7. PubMed ID: 6640529 [TBL] [Abstract][Full Text] [Related]
14. Mutagenic activities of oxidized derivatives of N-nitrosodipropylamine in the liver cell-mediated and Salmonella typhimurium assays. Langenbach R; Gingell R; Kuszynski C; Walker B; Nagel D; Pour P Cancer Res; 1980 Oct; 40(10):3463-7. PubMed ID: 7002287 [TBL] [Abstract][Full Text] [Related]
15. Mutagenic activation of selected aminoazo compounds by rat liver: evidence for a cytochrome P-448 dependent reaction. Mori Y; Niwa T; Toyoshi K Gan; 1983 Aug; 74(4):483-92. PubMed ID: 6414872 [TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of organic solvents on the mutagenicity of N-nitrosodialkylamines in Salmonella. Mori Y; Yamazaki H; Toyoshi K; Emi Y; Uchida K; Tsutsumi M; Konishi Y Mutat Res; 1985 Apr; 142(4):153-8. PubMed ID: 3885018 [TBL] [Abstract][Full Text] [Related]
17. The effects of pretreatment with cytochrome P-450 inducers and preincubation with a cytochrome P-450 effector on the mutagenicity of genotoxic carcinogens mediated by hepatic and renal S9 from two species of marine fish. Guobaitis RJ; Ellingham TJ; Maddock MB Mutat Res; 1986 Feb; 164(1):59-70. PubMed ID: 3512989 [TBL] [Abstract][Full Text] [Related]
18. Comparative activation of 3,3'-dichlorobenzidine and related benzidines to mutagens in the Salmonella typhimurium assay by hepatic S9 and microsomes from rats pretreated with different inducers of cytochrome P-450. Iba MM Mutat Res; 1987 Oct; 182(5):231-41. PubMed ID: 3309638 [TBL] [Abstract][Full Text] [Related]
19. High mutagenic activity of N-nitrosobis(2-oxopropyl)amine and N-nitrosobis(2-hydroxypropyl)amine in the host-mediated assay in hamsters: evidence for premutagenic methyl and hydroxylpropyl adducts. Guttenplan JB; Kokkinakis D Carcinogenesis; 1993 Aug; 14(8):1621-5. PubMed ID: 8353845 [TBL] [Abstract][Full Text] [Related]
20. Mutagenesis in Salmonella after metabolic activation of carcinogenic azo dyes and their isomers by liver S9 from rats, mice and hamsters. Mori Y; Niwa T; Toyoshi K; Hirano K; Sugiura M Mutat Res; 1983 Aug; 121(2):95-102. PubMed ID: 6348534 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]